Adarx 制药

最新新闻

• Emerging siRNA developer ADARx (ADRX.US) has launched a $350 million IPO, with AbbVie subscribing to a 4.9% stake and committing up to $100 million.
  Zhitong Finance · 2026/9/22

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。